Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elevance Health, Inc. Director's Dealing 2012

Dec 12, 2012

29933_dirs_2012-12-12_ce20bd5c-745b-4616-91b2-fdde181291e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WELLPOINT, INC (WLP)
CIK: 0001156039
Period of Report: 2012-12-10

Reporting Person: NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-10 Common Stock F 5182 $58.21 Disposed 100116.51 Direct

Footnotes

F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.